These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10452100)

  • 21. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of recombinant human interleukin-12 in male rhesus monkeys.
    Nadeau RR; Ostrowski C; Ni-Wu G; Liberato DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):78-83. PubMed ID: 7616451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
    Zheng J; Ma JY; Su Y; Yang J; Zhang RD; Zhou X; Wu RH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombopoietin induces p-selectin expression on platelets and subsequent platelet/leukocyte interactions.
    Tibbles HE; Navara CS; Hupke MA; Vassilev AO; Uckun FM
    Biochem Biophys Res Commun; 2002 Apr; 292(4):987-91. PubMed ID: 11944912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.
    Case BC; Hauck ML; Yeager RL; Simkins AH; de Serres M; Schmith VD; Dillberger JE; Page RL
    Stem Cells; 2000; 18(5):360-5. PubMed ID: 11007920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
    Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
    Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].
    Xie Y; Yan LZ; You T; Shi XL; Yan S; Zhai YY; Shang JJ; Yan Z; You HY; Wang QQ; Wu DP; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):505-511. PubMed ID: 38660859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
    Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.
    Akahori H; Shibuya K; Obuchi M; Nishizawa Y; Tsuji A; Kabaya K; Kusaka M; Ohashi H; Tsumura H; Kato T; Miyazaki H
    Br J Haematol; 1996 Sep; 94(4):722-8. PubMed ID: 8826901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- and multiple-dose pharmacokinetics of exendin-4 in rhesus monkeys.
    Ai G; Chen Z; Shan C; Che J; Hou Y; Cheng Y
    Int J Pharm; 2008 Apr; 353(1-2):56-64. PubMed ID: 18180118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice].
    Jiang J; Wang B; Yu X; Xu H; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1108-1112. PubMed ID: 31657334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.
    Vadhan-Raj S; Murray LJ; Bueso-Ramos C; Patel S; Reddy SP; Hoots WK; Johnston T; Papadopolous NE; Hittelman WN; Johnston DA; Yang TA; Paton VE; Cohen RL; Hellmann SD; Benjamin RS; Broxmeyer HE
    Ann Intern Med; 1997 May; 126(9):673-81. PubMed ID: 9139552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.
    Bolwell B; Vredenburgh J; Overmoyer B; Gilbert C; Chap L; Menchaca DM; Cruickshank S; Glaspy J
    Bone Marrow Transplant; 2000 Jul; 26(2):141-5. PubMed ID: 10918423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
    Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
    Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo biological effects of various forms of thrombopoietin in a murine model of transient pancytopenia.
    Thomas GR; Thibodeaux H; Errett CJ; Mathias J; Marian M; Meng G; Vandlen RL; Eaton DL
    Stem Cells; 1996; 14 Suppl 1():246-55. PubMed ID: 11012228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
    Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
    Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
    Farese AM; MacVittie TJ; Roskos L; Stead RB
    Stem Cells; 2003; 21(1):79-89. PubMed ID: 12529554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.